{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:58:40Z","timestamp":1780451920809,"version":"3.54.1"},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.56.7808","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T22:11:35Z","timestamp":1494799895000},"page":"1199-1202","source":"Crossref","is-referenced-by-count":12,"title":["Successful Treatment of Beh\u00e7et's Disease Associated with Acute Myeloid Leukemia with Myelodysplasia-related Changes Using Azacitidine and Tacrolimus before Allogeneic Hematopoietic Stem Cell Transplantation"],"prefix":"10.2169","volume":"56","author":[{"given":"Yukinori","family":"Nakamura","sequence":"first","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsuguma","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Tokunaga","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoru","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Yujiri","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Tanizawa","sequence":"additional","affiliation":[{"name":"Third Department of Internal Medicine, Yamaguchi University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Beh\u00e7et's disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol 24: S115-S119, 2006."},{"key":"2","unstructured":"2. Kawabata H, Sawaki T, Kawanami T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med 45: 1309-1314, 2006."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Toyonaga T, Nakase H, Matsuura M, et al. Refractoriness of intestinal Beh\u00e7et's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies: our case experience and review of the literature. Digestion 88: 217-221, 2013.","DOI":"10.1159\/000355341"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Beh\u00e7et disease. Int J Hematol 77: 82-85, 2003.","DOI":"10.1007\/BF02982607"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Tomonari A, Tojo A, Takahashi T, et al. Resolution of Beh\u00e7et's disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol 83: 464-466, 2004.","DOI":"10.1007\/s00277-003-0819-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Nonami A, Takenaka K, Sumida C, et al. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Beh\u00e7et's disease by up-front cord blood transplantation. Intern Med 46: 1753-1756, 2007.","DOI":"10.2169\/internalmedicine.46.0291"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weinberg OK, Seetharam M, Ren L, et al. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system. Blood 113: 1906-1908, 2009.","DOI":"10.1182\/blood-2008-10-182782"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lim SH, Hulsey M, Esler WV. Resolution of Behcet's disease after non-myeloablative allogeneic stem cell transplant for acute myeloid leukaemia. Rheumatology 48: 88-91, 2009.","DOI":"10.1093\/rheumatology\/ken413"},{"key":"9","first-page":"1078","volume":"335","year":"1990","unstructured":"9. Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease. Lancet 335: 1078-1080, 1990.","journal-title":"The Lancet","ISSN":"https:\/\/id.crossref.org\/issn\/0140-6736","issn-type":"print"},{"key":"10","unstructured":"10. G\u00fcl A. Pathogenesis of Beh\u00e7et's disease: autoinflammatory features and beyond. Semin Immunopathol 37: 413-418, 2015."},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet 373: 1550-1561, 2009.","DOI":"10.1016\/S0140-6736(09)60237-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Dombret H, Seymour JF, Butrym A, et al. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts. Blood 126: 291-299, 2015.","DOI":"10.1182\/blood-2015-01-621664"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Gr\u00f6vdal M, Karimi M, Khan R, et al. Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy. Br J Haematol 150: 293-302, 2010.","DOI":"10.1111\/j.1365-2141.2010.08235.x"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nishihori T, Perkins J, Mishra A, et al. Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome. Biol Blood Marrow Transplant 20: 776-780, 2014.","DOI":"10.1016\/j.bbmt.2014.02.008"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ikegawa S, Doki N, Kurosawa S, et al. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes. Leuk Lymphoma 57: 76-80, 2016.","DOI":"10.3109\/10428194.2015.1063148"},{"key":"16","unstructured":"16. de Lima M, Couriel D, Thall PF, et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 104: 857-864, 2004."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Jamil MO, Mineishi S. State-of-the-art acute and chronic GVHD treatment. Int J Hematol 101: 452-466, 2015.","DOI":"10.1007\/s12185-015-1785-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Matsumura K, Nakase H, Chiba T. Efficacy of oral tacrolimus on intestinal Behcet's disease. Inflamm Bowel Dis 16: 188-189, 2010.","DOI":"10.1002\/ibd.20970"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7808\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:39:29Z","timestamp":1569343169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/10\/56_56.7808\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.56.7808","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}